Deer IX & Co
Latest statistics and disclosures from Deer IX & Co's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Bright Health Group, Velo3d, Otonomo Technologies, Spire Global, KYMR, and represent 99.04% of Deer IX & Co's stock portfolio.
- Added to shares of these 4 stocks: Velo3d (+$285M), Otonomo Technologies (+$84M), Spire Global (+$82M), TCRX (+$9.3M).
- Started 4 new stock positions in TCRX, Spire Global, Velo3d, Otonomo Technologies.
- Reduced shares in these 2 stocks: Ncino (-$47M), KYMR (-$36M).
- Sold out of its position in Ncino.
- Deer IX & Co was a net buyer of stock by $377M.
- Deer IX & Co has $971M in assets under management (AUM), dropping by -12.10%.
- Central Index Key (CIK): 0001655220
Tip: Access up to 7 years of quarterly data
Positions held by Deer IX & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Deer IX & Co
Deer IX & Co holds 6 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Bright Health Group | 48.9 | $475M | 65M | 7.34 |
|
|
| Velo3d Common Stock | 29.4 | $285M | NEW | 38M | 7.53 |
|
| Otonomo Technologies Ordinary Shares | 8.6 | $84M | NEW | 20M | 4.30 |
|
| Spire Global Com Cl A | 8.4 | $82M | NEW | 7.3M | 11.28 |
|
| Kymera Therapeutics (KYMR) | 3.7 | $36M | -50% | 616k | 58.74 |
|
| Tscan Therapeutics (TCRX) | 1.0 | $9.3M | NEW | 1.2M | 7.51 |
|
Past Filings by Deer IX & Co
SEC 13F filings are viewable for Deer IX & Co going back to 2020
- Deer IX & Co 2021 Q2 restated filed Nov. 24, 2021
- Deer IX & Co 2021 Q3 filed Nov. 15, 2021
- Deer IX & Co 2021 Q2 filed Aug. 16, 2021
- Deer IX & Co 2021 Q1 filed May 14, 2021
- Deer IX & Co 2020 Q4 filed Feb. 16, 2021